Aspira Women's Health Announces Publication Of Second-Generation MultiVariate Index Assay, OVERA, In Detection Of Cancer In Filipino Women
Author: Benzinga Newsdesk | September 12, 2022 04:30pm
Aspira Women's Health Inc. ("Aspira"), a bio-analytical based women's health company focused on gynecologic disease, today announced publication of a study on the use of its multivariate index assay, MIA2G (OVERA®), in the detection of ovarian cancer in Filipino women in the peer-reviewed International Journal of Environmental Research and Public Health.
Posted In: AWH